- The Valens Company to begin production and bottling of 1,300
litres of hand sanitizer liquid at its Kelowna facility.
- The Company will distribute 40,000 sanitizer bottles to
frontline healthcare workers in Canada.
- Significant quantities of PPE Gear has been donated, including
gloves, gowns and sanitizing wipes, with a second shipment of masks
expected soon.
KELOWNA, BC, April 8, 2020 /CNW/ - Valens GroWorks
Corp. (TSXV: VLNS) (OTCQX: VLNCF) (the
"Company", "Valens" or "The Valens Company"), a
global leader in the end-to-end development and manufacturing of
innovative, cannabinoid-based products, today announced that it
will begin production of hand sanitizer liquid with an initial
1,300 litre-batch at its Kelowna
facility to help alleviate product supply shortages as a result of
the COVID-19 health crisis.
The Valens Company will bottle and donate 40,000 bottles of
hand sanitizer in various formats to frontline health care workers
across Canada. The Company is
focusing on British Columbia,
Alberta and Ontario for distribution, as well as providing
10,000 units to Shoppers Drug Mart to aid their public-facing
workers at pharmacies across Canada. Simultaneously, the company is working
with hospital networks, all essential services and various
associations servicing the vulnerable, to distribute supplies to
those who need it most.
Valens has also donated significant quantities of various
personal protective equipment (PPE) such as gloves, gowns, and
sanitizing wipes from the Company's existing supply. The Company is
also expecting a second shipment of PPE gear, including masks,
which will also be donated to healthcare workers.
"We at The Valens Company recognize the urgency in assisting our
communities across the country during this critical phase of the
COVID-19 pandemic," said Tyler
Robson, CEO, The Valens Company. "We consider it our
corporate responsibility to leverage our existing extraction and
production capabilities to distribute products that have the
potential to fight the transmission of this virus. We are quickly
mobilizing our teams and resources to alleviate essential supply
shortages and contribute as much as we can to those selflessly
helping on the frontlines."
About The Valens Company
The Valens Company is a
global leader in the end-to-end development and manufacturing of
innovative, cannabinoid-based products. The Company is focused on
being the partner of choice for leading Canadian and international
cannabis brands by providing best-in-class, proprietary services
including CO2, ethanol, hydrocarbon, solvent-less and terpene
extraction, analytical testing, formulation and white-label product
development and manufacturing. Valens is the largest third-party
extraction Company in Canada with
an annual capacity of 425,000 kg of dried cannabis and hemp biomass
at our purpose-built facility in Kelowna,
British Columbia which is in the process of becoming
European Union (EU) Good Manufacturing Practices (GMP) compliant.
The Valens Company currently offers a wide range of product
formats, including tinctures, two-piece caps, soft gels, oral
sprays and vape pens as well as beverages, concentrates, topicals,
edibles, injectables, natural health products and has a strong
pipeline of next-generation products in development for future
release. Finally, the Company's wholly-owned subsidiary
Valens Labs is a Health Canada
licensed ISO 17025 accredited cannabis testing lab providing
sector-leading analytical services and has partnered with Thermo
Fisher Scientific to develop a Centre of Excellence in Plant-Based
Science. or more information, please visit
http://thevalenscompany.com. The Company's investor deck can
be found specifically at http://thevalenscompany.com/investors/.
Notice regarding Forward Looking Statements
All information included in this press release, including any
information as to the future financial or operating performance and
other statements of The Valens Company that express management's
expectations or estimates of future performance, other than
statements of historical fact, constitute forward-looking
information or forward-looking statements within the meaning of
applicable securities laws and are based on expectations, estimates
and projections as of the date hereof. Forward-looking statements
are included for the purpose of providing information about
management's current expectations and plans relating to the future.
Wherever possible, words such as "plans", "expects", "scheduled",
"trends", "indications", "potential", "estimates", "predicts",
"anticipate", "to establish", "believe", "intend", "ability to", or
statements that certain actions, events or results "may", "could",
"would", "might", "will", or are "likely" to be taken, occur or be
achieved, or the negative of these words or other variations
thereof, have been used to identify such forward-looking
information. Specific forward-looking statements include, without
limitation, all disclosure regarding future results of operations,
economic conditions and anticipated courses of action.
The risks and uncertainties that may affect forward-looking
statements include, among others, regulatory risk,
United States border crossing and
travel ban, reliance on licenses, expansion of facilities,
competition, dependence on supply of cannabis and reliance on other
key inputs, dependence on senior management and key personnel,
general business risk and liability, regulation of the cannabis
industry, change in laws, regulations and guidelines, compliance
with laws, reliance on a single facility, limited operating
history, vulnerability to rising energy costs, unfavourable
publicity or consumer perception, product liability, risks related
to intellectual property, product recalls, difficulties with
forecasts, management of growth and litigation, many of which are
beyond the control of The Valens Company. For a more comprehensive
discussion of the risks faced by The Valens Company, and which may
cause the actual financial results, performance or achievements of
The Valens Company to be materially different from estimated future
results, performance or achievements expressed or implied by
forward-looking information or forward-looking statements, please
refer to The Valens Company's latest Annual Information Form filed
with Canadian securities regulatory authorities at www.sedar.com or
on The Valens Company's website at www.thevalenscompany.com. The
risks described in such Annual Information Form are hereby
incorporated by reference herein. Although the forward-looking
statements contained herein reflect management's current beliefs
and reasonable assumptions based upon information available to
management as of the date hereof, The Valens Company cannot be
certain that actual results will be consistent with such
forward-looking information. The Valens Company cautions you not to
place undue reliance upon any such forward-looking statements. The
Valens Company disclaims any intention or obligation to update or
revise any forward-looking statements whether as a result of new
information, future events or otherwise, except as required by
applicable law. Nothing herein should be construed as either an
offer to sell or a solicitation to buy or sell securities of The
Valens Company.
The TSXV or other regulatory authority has not reviewed,
approved or disapproved the contents of this press release. We seek
Safe Harbour.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/the-valens-company-begins-production-of-hand-sanitizer-to-help-combat-covid-19-pandemic-301036954.html
SOURCE The Valens Company